CLEARVISE AG (ABO.DE) Fundamental Analysis & Valuation

FRA:ABO • DE000A1EWXA4

Current stock price

1.24 EUR
0 (0%)
Last:

This ABO.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ABO.DE Profitability Analysis

1.1 Basic Checks

  • In the past year ABO has reported negative net income.
  • In the past year ABO had a positive cash flow from operations.
  • ABO had positive earnings in 4 of the past 5 years.
  • In the past 5 years ABO always reported a positive cash flow from operatings.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.17%, ABO is doing worse than 68.18% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -0.44%, ABO is doing worse than 68.18% of the companies in the same industry.
  • With a Return On Invested Capital value of 0.99%, ABO is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for ABO is below the industry average of 5.34%.
Industry RankSector Rank
ROA -0.17%
ROE -0.44%
ROIC 0.99%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.96%
ROIC(5y)2.52%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • With a decent Operating Margin value of 18.27%, ABO is doing good in the industry, outperforming 72.73% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ABO has declined.
  • ABO's Gross Margin of 96.58% is amongst the best of the industry. ABO outperforms 95.45% of its industry peers.
  • In the last couple of years the Gross Margin of ABO has remained more or less at the same level.
Industry RankSector Rank
OM 18.27%
PM (TTM) N/A
GM 96.58%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ABO.DE Health Analysis

2.1 Basic Checks

  • ABO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ABO has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ABO has been increased compared to 5 years ago.
  • Compared to 1 year ago, ABO has a worse debt to assets ratio.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of 0.53, we must say that ABO is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ABO (0.53) is worse than 63.64% of its industry peers.
  • ABO has a debt to FCF ratio of 22.35. This is a negative value and a sign of low solvency as ABO would need 22.35 years to pay back of all of its debts.
  • ABO has a better Debt to FCF ratio (22.35) than 72.73% of its industry peers.
  • A Debt/Equity ratio of 1.35 is on the high side and indicates that ABO has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.35, ABO is in line with its industry, outperforming 40.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 22.35
Altman-Z 0.53
ROIC/WACC0.29
WACC3.45%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • ABO has a Current Ratio of 1.61. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
  • ABO has a Current ratio (1.61) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.61 indicates that ABO should not have too much problems paying its short term obligations.
  • The Quick ratio of ABO (1.61) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.61
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ABO.DE Growth Analysis

3.1 Past

  • The earnings per share for ABO have decreased strongly by -89.42% in the last year.
  • ABO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.53%.
  • ABO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.75% yearly.
EPS 1Y (TTM)-89.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%3.62%

3.2 Future

  • ABO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.65% yearly.
  • ABO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.97% yearly.
EPS Next Y87.82%
EPS Next 2Y115%
EPS Next 3Y64.65%
EPS Next 5YN/A
Revenue Next Year10.19%
Revenue Next 2Y13.51%
Revenue Next 3Y7.97%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

More info and screens

Find the best growth stocksShow best growing peers

5

4. ABO.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ABO. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 17.13, ABO is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ABO indicates a somewhat cheap valuation: ABO is cheaper than 68.18% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.09, ABO is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 17.13
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

  • ABO's Enterprise Value to EBITDA ratio is in line with the industry average.
  • ABO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ABO is cheaper than 86.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.84
EV/EBITDA 13.65
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • ABO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ABO's earnings are expected to grow with 64.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y115%
EPS Next 3Y64.65%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ABO.DE Dividend Analysis

5.1 Amount

  • ABO has a Yearly Dividend Yield of 4.84%, which is a nice return.
  • ABO's Dividend Yield is rather good when compared to the industry average which is at 2.28. ABO pays more dividend than 90.91% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, ABO pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.84%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABO.DE Yearly Dividends per shareABO.DE Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2Y115%
EPS Next 3Y64.65%
ABO.DE Yearly Income VS Free CF VS DividendABO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ABO.DE Fundamentals: All Metrics, Ratios and Statistics

CLEARVISE AG

FRA:ABO (4/20/2026, 7:00:00 PM)

1.24

0 (0%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-14
Earnings (Next)04-30
Inst Owners6.34%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap93.45M
Revenue(TTM)35.41M
Net Income(TTM)-707.70K
Analysts85.71
Price Target2.82 (127.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.84%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.13
P/S 2.64
P/FCF 8.84
P/OCF 8.84
P/B 0.58
P/tB 0.58
EV/EBITDA 13.65
EPS(TTM)-0.01
EYN/A
EPS(NY)0.07
Fwd EY5.84%
FCF(TTM)0.14
FCFY11.32%
OCF(TTM)0.14
OCFY11.32%
SpS0.47
BVpS2.13
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.17%
ROE -0.44%
ROCE 1.64%
ROIC 0.99%
ROICexc 1.05%
ROICexgc 1.05%
OM 18.27%
PM (TTM) N/A
GM 96.58%
FCFM 29.86%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.96%
ROIC(5y)2.52%
ROICexc(3y)3.53%
ROICexc(5y)2.94%
ROICexgc(3y)3.56%
ROICexgc(5y)2.99%
ROCE(3y)4.91%
ROCE(5y)4.17%
ROICexgc growth 3Y9.45%
ROICexgc growth 5Y-12.72%
ROICexc growth 3Y10.45%
ROICexc growth 5Y-12.08%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 1.35
Debt/FCF 22.35
Debt/EBITDA 9.67
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 47.02%
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 1.61
Altman-Z 0.53
F-Score4
WACC3.45%
ROIC/WACC0.29
Cap/Depr(3y)124.13%
Cap/Depr(5y)91.46%
Cap/Sales(3y)46.11%
Cap/Sales(5y)37.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y87.82%
EPS Next 2Y115%
EPS Next 3Y64.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%3.62%
Revenue Next Year10.19%
Revenue Next 2Y13.51%
Revenue Next 3Y7.97%
Revenue Next 5YN/A
EBIT growth 1Y-60.34%
EBIT growth 3Y29.64%
EBIT growth 5Y-1.33%
EBIT Next Year435.45%
EBIT Next 3Y84.85%
EBIT Next 5YN/A
FCF growth 1Y-70.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-74.97%
OCF growth 3Y-7.16%
OCF growth 5Y-8.38%

CLEARVISE AG / ABO.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CLEARVISE AG?

ChartMill assigns a fundamental rating of 4 / 10 to ABO.DE.


Can you provide the valuation status for CLEARVISE AG?

ChartMill assigns a valuation rating of 5 / 10 to CLEARVISE AG (ABO.DE). This can be considered as Fairly Valued.


How profitable is CLEARVISE AG (ABO.DE) stock?

CLEARVISE AG (ABO.DE) has a profitability rating of 3 / 10.


How financially healthy is CLEARVISE AG?

The financial health rating of CLEARVISE AG (ABO.DE) is 3 / 10.